Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACUS: Levocetirizine + Tranexamic Acid in Chronic Spontaneous Urticaria
NCT03789422Phase 4Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in chronic spontaneous urticaria (CSU), sponsored by CHU Grenoble Alpes. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT03789422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789422.